APA (7th ed.) Citation

N, B., LK, B., A, U., JE, N., SE, J., PS, M., . . . AI, L. (2020). Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: Kinetic profile, relationship to interleukin 6 and infarct size. European heart journal. Acute cardiovascular care, 9(4), 302. https://doi.org/10.1177/2048872620923641

Chicago Style (17th ed.) Citation

N, Butt, et al. "Pentraxin 3 in Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction Is Associated with Early Irreversible Myocardial Damage: Kinetic Profile, Relationship to Interleukin 6 and Infarct Size." European Heart Journal. Acute Cardiovascular Care 9, no. 4 (2020): 302. https://doi.org/10.1177/2048872620923641.

MLA (9th ed.) Citation

N, Butt, et al. "Pentraxin 3 in Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction Is Associated with Early Irreversible Myocardial Damage: Kinetic Profile, Relationship to Interleukin 6 and Infarct Size." European Heart Journal. Acute Cardiovascular Care, vol. 9, no. 4, 2020, p. 302, https://doi.org/10.1177/2048872620923641.